Industry

Verified for compliance with European and U.S. regulatory and assessment frameworks, aiming to help reduce traffic accidents caused by drunk driving TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation (TOKYO: 6503) announced today that it has developed a technology that accurately detects intoxication levels indicated by driver distraction and drowsiness, and provides driver alerts and vehicle-control interventions as needed … [Read more…]

The Health Care Authority (HCA) and Department of Health (DOH) are equipping health care providers and emergency medical services (EMS) personnel with practical, research-based resources to expand treatment access and reduce overdose deaths. OLYMPIA, Wash.–(BUSINESS WIRE)–The Washington State Health Care Authority (HCA) and Department of Health (DOH) just released a new resource library to help … [Read more…]

John Johnson, current board member, appointed to chairman of the board Michael Kauffman, M.D., Ph.D., lead director since 2016, appointed to president of development Commercial launch progresses as RAMP 301 Phase 3 confirmatory trial in recurrent LGSOC completes additional patient enrollment; topline data anticipated in mid-2027 BOSTON–(BUSINESS WIRE)–Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed … [Read more…]

Sixth late-breaking presentation from CONFIRM2 Registry demonstrates 12-fold risk gradient based on total plaque burden DENVER–(BUSINESS WIRE)–#AI—Cleerly, a leader in AI-based cardiovascular imaging, presented new, late-breaking science from the international CONFIRM2 Registry at the Global CVCT Scientific Program 2025 in Washington, DC. The study, “AI-Guided Quantification of Atherosclerosis on Coronary CT for Identification of High-Risk … [Read more…]

ST. LOUIS–(BUSINESS WIRE)–Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures. The financing is intended to accelerate Cofactor’s nationwide expansion and broaden patient access to its immunotherapy-response diagnostics. Ascension Ventures, the strategic investment arm of 13 leading U.S. health systems across 22 … [Read more…]

Company reiterates fiscal 2026 guidance Company raises long-term guidance expectations to reflect OneOncology’s expected long-term contribution to enterprise growth CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–Cencora, Inc. (NYSE: COR) today announced it has entered into a definitive agreement to acquire the majority of the outstanding equity interests that it does not currently own in OneOncology, a physician-led national platform … [Read more…]

ATHENS, Greece–(BUSINESS WIRE)–  ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GENESIS Pharma, a regional biopharma company focused on the commercialization of innovative medicines in Central and Eastern Europe, announces an exclusive agreement with Otsuka Pharmaceutical Europe Ltd. (OPEL), the European operation of global healthcare company Otsuka Pharmaceutical Co., Ltd., … [Read more…]

Reduces surface-bound viruses, bacteria and odors for safe, secure, and comfortable indoor environment TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation (TOKYO: 6503) announced today that in collaboration with Professor Toshiaki Kamachi and colleagues from the School of Life Science and Technology at Institute of Science Tokyo (Science Tokyo) they have achieved the world’s first mechanism for elucidating the … [Read more…]

Company to host webcast Monday, December 15, 2025 at 8:30 a.m. ET BOTHELL, Wash.–(BUSINESS WIRE)–Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the company will host a conference call and webcast on Monday, December 15, 2025 at 8:30 am ET to disclose the topline results … [Read more…]

Precision biomarker company’s Scientific Advisory Board includes multiple Nobel Prize winners and the creators of current gold standard in Parkinson’s disease progression CAMBRIDGE, Mass., AUSTIN, Texas & TEL AVIV, Israel–(BUSINESS WIRE)–NeuraLight, the leader in developing precision biomarkers for neurological disease, today announced that Prof. Thomas Südhof, a Nobel Prize-winning neuroscientist and one of the world’s … [Read more…]